SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-20-017582
Filing Date
2020-08-05
Accepted
2020-08-05 17:20:50
Documents
69
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q brhc10013956_10q.htm   iXBRL 10-Q 1629641
2 EXHIBIT 10.2 brhc10013956_10-2.htm EX-10.2 45984
3 EXHIBIT 31.1 brhc10013956_ex31-1.htm EX-31.1 11212
4 EXHIBIT 31.2 brhc10013956_ex31-2.htm EX-31.2 11116
5 EXHIBIT 32.1 brhc10013956_ex32-1.htm EX-32.1 6235
11 image0.jpg GRAPHIC 26227
12 image1.jpg GRAPHIC 27452
  Complete submission text file 0001140361-20-017582.txt   6945571

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA rckt-20200630.xsd EX-101.SCH 47955
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rckt-20200630_cal.xml EX-101.CAL 62254
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rckt-20200630_def.xml EX-101.DEF 210485
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rckt-20200630_lab.xml EX-101.LAB 703861
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rckt-20200630_pre.xml EX-101.PRE 365787
13 EXTRACTED XBRL INSTANCE DOCUMENT brhc10013956_10q_htm.xml XML 1021632
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36829 | Film No.: 201078640
SIC: 2834 Pharmaceutical Preparations